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Helicobacter pylori Infection is Associated with Elevated Low 
Density Lipoprotein Cholesterol Levels in Elderly Koreans 
This study was conducted to investigate the association between Helicobacter pylori (H. 
pylori) infection and the lipid profile among elderly Koreans. A total of 462 subjects (mean 
age 66.2 ± 7.6 yr, 84% males) who underwent health check-up were investigated. Each 
subject underwent gastroduodenoscopy with gastric mucosal biopsy, and H. pylori 
infection was determined by histopathological examination using the updated Sydney 
System score. The presence of H. pylori infection was significantly associated with the 
elevated serum levels of total cholesterol and low density lipoprotein (LDL) cholesterol (P < 
0.05 for each) in univariate analysis. H. pylori infection was not associated with triglyceride 
and high density lipoprotein (HDL) cholesterol levels (P > 0.05 for each). After controlling 
confounders, multiple logistic regression analysis showed that the odds ratio of H. pylori 
infection for high LDL cholesterol level (> 140 mg/dL) was 3.113 (95% confidence interval, 
1.364-7.018; P = 0.007). There were no significant associations between the presence of 
H. pylori infection and elevated total cholesterol levels (> 200 mg/dL) in this model (P = 
0.586). The results of this study demonstrate that H. pylori infection is associated with the 
elevated serum LDL cholesterol levels in elderly Koreans, supporting the hypothesis that H. 
pylori plays a role in promoting atherosclerosis by modifying lipid metabolism.
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Helicobacter pylori (H. pylori) induces chronic inflammation of 
underlying mucosa of the human stomach causing gastritis and 
peptic ulceration (1). A number of previous studies have sug-
gested that mild systemic inflammation provoked by H. pylori 
infection is associated with metabolic syndrome and athero-
sclerotic cardiovascular disease (2-6). However, some studies 
could not confirm this association (7-9). The underlying mech-
anisms of how H. pylori infection promotes the development of 
such diseases still remain unclear. 
  Modified blood cholesterol levels, such as elevated low den-
sity lipoprotein (LDL) and decreased high density lipoprotein 
(HDL), are major risk factors for cardiovascular disease and met-
abolic syndrome (10). The effect of H. pylori infection on the se-
rum lipid profile is still a matter of debate. Several studies have 
demonstrated that H. pylori infection might modify serum lipid 
concentrations through increase the risk of atherosclerosis (10-
13), while others have not confirmed these findings (14, 15). 
  The purpose of this study was to investigate the association 




We recruited 775 subjects who underwent upper gastrointesti-
nal (GI) endoscopic examination during routine health check-
up at the Armed Forces Seoul Hospital (Seoul, Korea) from Jan-
uary 1, 2005 to December 31, 2009. Gastric mucosal biopsy spec-
imens were obtained from 558 of these subjects. In total, 103 
subjects were excluded according to the following criteria: 1) 
subjects who had a history of H. pylori eradication or gastric sur-
gery, 2) those who had already received anti-hyperlipidemic 
therapy, 3) those suffering from acute of chronic inflammatory 
conditions, severe liver or renal dysfunction, or malignancy, and 
4) those who had not information available for the study vari-
ables. Finally, a total of 454 subjects were included in the study. 
Data collection
Information regarding the underlying diseases, medication his-
tory, alcohol drinking, and exercise habits was recorded by a 
trained family medicine doctor using a standardized question-
naire. Systolic/diastolic blood pressures (SBP/DBP), body weight 
and height were measured by a trained nurse. The body mass 
index (BMI) was calculated by the ratio of weight (kg)/squared Kim H-L, et al.  •  HP Infection and LDL Cholesterol 
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height (m
2). Hypertension was physician-reported for an SBP 
of ≥ 140 mmHg, a DBP of ≥ 90 mmHg, or a history of the use of 
anti-hypertensive medications. Diabetes was determined by 
physician reports based on a fasting blood sugar level of ≥ 126 
mg/dL or a history of the use of medications for diabetes. After 
an overnight fast (≥ 12 hr), 10 mL of venous blood was obtained 
from the antecubital vein of each subject. The hemoglobin level 
was analyzed by an automated blood cell counter (ADVIA 120, 
Bayer, NY, USA). Total cholesterol, LDL cholesterol, HDL cho-
lesterol, triglyceride, alanine aminotransferase, fasting blood 
sugar and creatinine levels were measured by enzymatic meth-
ods using an automated chemistry analyzer (Toshiba TBA-120 
FR, Toshiba Medical Systems, Tokyo, Japan). 
Histology
Endoscopic gastric mucosal biopsies were performed by skilled 
endoscopists. Two or three biopsy specimens were taken from 
either the gastric body (n = 237, 52.2%), antrum (n = 196, 43.2%) 
or cardia (n = 21, 4.6%). The specimens were fixed in 10% forma-
lin, embedded in paraffin block on the oriented edge, and cut 
into 4 μm-thick sections. All sections were stained with hema-
toxylin-eosin and Giemsa for histological evaluation. The pres-
ence and intensity of H. pylori were microscopically examined. 
Each stained slide was interpreted semiquantitatively as none, 
mild, moderate and severe, according to the updated Sydney 
System (16) (Fig. 1). The density of H. pylori was evaluated by 2 
independent pathologists using a light microscope in a blinded 
fashion. Discordant cases were reviewed on a multi-headed 
microscope to achieve a consensus.  
 
Statistical analysis
Data are presented as mean values with standard deviation or 
percentage. For univariate analysis, continuous variables were 
compared using the Student’s t-test and categorical variables 
were compared using the chi-square test. The crude odds ratios 
(cORs) and adjusted odds ratios (aOR) of H. pylori infection for 
elevated total cholesterol and LDL cholesterol were tested with 
the chi-square test and multiple logistic regression analysis, re-
spectively. Age, sex, BMI, cigarette smoking, alcohol drinking, 
regular exercise, hypertension, diabetes, SBP, DBP, fasting blood 
sugar and creatinine were adjusted during the logistic regres-
sion analysis. LDL cholesterol levels according to the H. pylori 
severity were analyzed by using analysis of variance (ANOVA). 
Elevated total cholesterol and LDL cholesterol levels were iden-
A B
C D
Fig. 1. Helicobacter pylori gastritis in endoscopic biopsy. The degree of H. pylori infection is shown according to the updated Sydney classification; none (A), mild (B), moderate 
(C), and severe (D) (Giemsa staining, × 400). Kim H-L, et al.  •  HP Infection and LDL Cholesterol 
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tified as values greater than 200 and 140 mg/dL, respectively. A 
two-tailed P value of < 0.05 was considered statistically signifi-
cant. All data were analyzed using SPSS for Windows v.13.0 (SPSS 
Inc, Chicago, IL, USA). 
Ethics statement 
The study protocol was approved bt the institutional review board 
of the Armed Forces Medical Command (Seongnam, Korea, re-
search number AFMC-10-IRB-018). Written informed consent 
was obtained from each participant before endoscopy.
RESULTS
Among 454 study subjects (mean age 66.2 ± 7.6 yr, 84% males), 
45 had normal upper GI endoscopic findings, 385 had gastritis, 
and 24 had peptic ulcer disease. Gastric mucosal biopsy showed 
that 193 subjects (42.5%) were positive for H. pylori. Table 1 com-
pared clinical characteristics between H. pylori (+) and H. pylori 
(-) subjects. Subjects with H. pylori (+) were younger (65.1 ± 7.7 
vs 67.0 ± 7.4 yr, P = 0.008) and had a lower incidence of diabetes 
(4.2% vs 7.8%, P = 0.010) compared to those with H. pylori (-). 
The other clinical and laboratory parameters including BMI, 
smoking, alcohol consumption, regular exercise, blood pres-
sure, hemoglobin, alanine aminotransferase, albumin, fasting 
blood sugar and creatinine, were not different between the 2 
groups (P > 0.05). 
  Total cholesterol (184.6 ± 29.6 vs 177.4 ± 31.0 mg/dL, P = 0.014) 
and LDL cholesterol (138.5 ± 33.0 vs 121.3 ± 30.6 mg/dL, P < 
0.001) were significantly elevated in the subjects with H. pylori 
(+) compared to those with H. pylori (-). There were no signifi-
cant differences in other lipid profile, including HDL cholester-
ol and triglyceride, between the 2 groups (P > 0.05).   
  Table 2 shows that the ORs of H. pylori (+) for elevated total 
cholesterol (> 200 mg/dL) and LDL cholesterol (> 140 mg/dL). 
H. pylori (+) was significantly associated with elevated total cho-
lesterol (cOR 1.476, 95% CI 1.015-2.145, P = 0.041), however, this 
significance disappeared after adjustment for confounders in-
cluding age, sex, BMI, cigarette smoking, alcohol drinking, reg-
ular exercise, hypertension, diabetes, SBP, DBP, fasting blood 
sugar and creatinine (aOR 1.241, 95% CI 0.571-2.698, P = 0.586). 
In contrast, H. pylori (+) was significantly associated with ele-
vated LDL cholesterol even after adjustment for potential con-
founders (cOR 2.709, 95% CI 1.845-3.980, P < 0.001; aOR 3.113, 
95% CI 1.364-7.108, P = 0.007). 
  Among 193 subjects with H. pylori (+), 100 (51.8%) had a mild 
degree of H. pylori infection, 38 (19.6%) had a moderate degree 
of H. pylori infection, and 55 (28.6%) had a severe degree of H. 
pylori infection on histological examination. Fig. 2 shows LDL 
cholesterol levels according to the severity of H. pylori infection. 
As H. pylori severity increased, the blood LDL cholesterol level 
increased gradually. LDL cholesterol levels were 121.3 ± 30.6, 
Table 1. Characteristics of study participants
Characteristics Total  
(n = 454)
HP (+)  
(n = 193)
HP (-) 
(n = 261) P value* 
Age (yr) 66.2 ± 7.6 65.1 ± 7.7 67.0 ± 7.4 0.008
Male sex (%) 83.9 81.3 85.8 0.199
BMI (kg/m
2) 24.1 ± 2.2 24.1 ± 2.2 24.0 ± 2.2 0.800
Cigarette smoking (%) 55.1 52.8 56.8 0.661
Alcohol drinking (%) 66.9 71.7 66.2 0.512
Regular exercise (%) 76.2 71.7 79.5 0.313
Hypertension (%) 15.3 16.1 14.7 0.667
Diabetes (%)   8.0   4.2   7.8 0.010
SBP (mmHg) 126.3 ± 14.0 125.7 ± 13.7 126.7 ± 14.1 0.438
DBP (mmHg) 78.2 ± 8.3 78.2 ± 8.0 78.2 ± 8.6 0.917
Hb (g/dL) 14.1 ± 1.1 14.1 ± 1.1 14.1 ± 1.2 0.992
ALT (IU/L)   22.9±13.6   23.4±16.2   22.5±11.3 0.469
Albumin (g/dL)   4.06 ± 0.18   4.05 ± 0.18   4.06 ± 0.18 0.675
FBS (mg/dL)   99.8 ± 16.1   99.4 ± 13.8 100.1 ± 17.7 0.599
Creatinine (mg/dL)   0.84 ± 0.15   0.83 ± 0.15   0.84 ± 0.15 0.539
Total cholesterol (mg/dL) 180.5 ± 30.6 184.6 ± 29.6 177.4 ± 31.0 0.014
HDL cholesterol (mg/dL)   51.8 ± 11.8   51.7 ± 11.3   51.9 ± 12.1 0.892
LDL cholesterol (mg/dL) 128.6 ± 32.7 138.5 ± 33.0 121.3 ± 30.6 < 0.001
Triglyceride (mg/dL)  106.1 ± 63.6 110.9 ± 68.3 102.4 ± 59.8 0.161
Values are expressed as mean ± standard deviation or number. *P values were 
obtained by comparison between HP (+) and HP (-) groups. HP, Helicobactor pylroi; 
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; 
Hb, hemoglobin; ALT, alanine aminotransferase; FBS, fasting blood sugar; HDL, high 
density lipoprotein; LDL, low density lipoprotein.
Table 2. Odds ratios of Helicobacter pylori infection for high total cholesterol and LDL 
cholesterol
Odds ratio  95% CI P value
High total cholesterol (≥ 180 mg/dL)
   Crude 










High LDL cholesterol (≥ 130 mg/dL)
   Crude 










*Adjusted for age, sex, body mass index, cigarette smoking, alcohol drinking, regular 
exercise, hypertension, diabetes, systolic and diastolic blood pressure, fasting blood 





























Degree of Helicobactor pylori infection
P < 0.001 by ANOVA
  None (n = 261)  Mild or moderate (n = 138)  Severe (n = 55)
*
Fig. 2. Blood LDL cholesterol levels according to the degree of Helicobactor pylori 
infection. As H. pylori severity increases, blood LDL cholesterol levels also increase 
gradually. LDL cholesterol levels were 121.3 ± 30.6, 132.7 ± 30.5 and 153.0 ± 35.1 
mg/dL in the absence of H. pylori infection, and mild or moderate and severe degrees 
of H. pylori infection, respectively. *P < 0.01 versus other two groups by Bonferroni 
post-hoc analysis. LDL, low density lipoprotein; ANOVA, analysis of variance.Kim H-L, et al.  •  HP Infection and LDL Cholesterol 
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132.7 ± 30.5 and 153.0 ± 35.1 mg/dL in the none, mild or mod-
erate and severe degrees of H. pylori infection, respectively (P < 
0.001). 
DISCUSSION
The results of this study showed that H. pylori infection was in-
dependently associated with elevated LDL cholesterol levels in 
elderly Koreans. LDL cholesterol levels were higher in subjects 
with H. pylori infection, and LDL cholesterol levels increased 
with increasing H. pylori severity. The odds ratio H. pylori infec-
tion for elevated LDL cholesterol (LDL > 140 mg/dL) was 3.113. 
These findings suggest that H. pylori infection may cause lipid 
alteration and, at least partially contribute to the atherosclerotic 
process.
  The prevalence of H. pylori infection was 42.5% in our study, 
which is similar to that in a previous study of the Korean popu-
lation demonstrating younger age and smoking history as risk 
factors of H. pylori infection (17). In our study, H. pylori infec-
tion was associated with younger age by univariate analysis, but 
not with smoking.
  Systemic inflammatory response to the bacterium induces 
changes in lipid and lipoprotein metabolism (18). Although pre-
vious studies on the association between H. pylori infection and 
lipid profiles showed contradictory results, there is a general 
agreement that H. pylori infection itself modifies serum lipid pro-
files (3, 4, 11-13, 19, 20). Patients infected with H. pylori showed 
an atherogenic lipid profile characterized by an increase in LDL 
cholesterol or decreased HDL cholesterol compared to unin-
fected patients (5, 11, 12, 19-22). Our result also provided addi-
tional evidence supporting the hypothesis that H. pylori played 
a role in inducing atherosclerosis with lipid metabolism by ele-
vating LDL cholesterol levels. Based on these results, it is con-
ceivable that H. pylori infection is a predisposing factor for the 
atherosclerotic process and can be a reliable indicator for the 
assessment of cardiovascular disease risk.  
  H. pylori infection was confirmed by the presence of serum 
H. pylori-specific antibody in most of the previous studies on 
the relationship between H. pylori infection and lipid profile (2, 
3, 5, 20). Although the serologic diagnosis of H. pylori infection 
has a high diagnostic accuracy, it is an indirect method. Thus, 
histological detection remains the standard for the diagnosis of 
H. pylori infection (23). A few studies have investigated the asso-
ciation between H. pylori infection and lipid profiles by histo-
pathological examination (4). In our study, H. pylori infection 
was confirmed with the histopathological examination of the 
biopsied specimens. We graded the severity of H. pylori infec-
tion based on the updated Sydney System score (16) and showed 
that serum LDL cholesterol levels gradually increased along 
with H. pylori severity. The updated Sydney System has been 
widely employed to assess the severity and activity of gastric in-
flammation (16). Kucukazman et al. (4) also used the Sydney 
System score and demonstrated the correlation between histo-
logical evaluation of H. pylori and LDL cholesterol levels; how-
ever, they did not adjust for confounders.   
  There are some limitations that should be acknowledged in 
this study. Because of cross-sectional design of this study, the 
relationship between H. pylori infection and LDL cholesterol 
levels could not be conclusively proven. Longitudinal studies 
are required to confirm our results. Assessing serum LDL cho-
lesterol levels before and after H. pylori eradication may be a 
good example (19, 24). Also, there would be a possibility of un-
derestimating the number of subjects infected with H. pylori 
because H. pylori infection was diagnosed solely based on the 
histological detection of biopsied specimens from focal lesions. 
  In our conclusion, the results of this study suggest that H. py-
lori infection can be associated with elevated LDL cholesterol 
levels, the most important risk factor for atherosclerosis, and 
that eradication of H. pylori may play a role in preventing ath-
erosclerosis by decreasing LDL cholesterol levels, particularly 
in elderly Koreans.
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